OpenAI unveils GPT-Rosalind to surface new drug leads for neurodegenerative diseases
gdb · x · 2026-11-21
OpenAI, together with perturbaitx and Scripps Research, announced GPT-Rosalind, showing how AI helps scientists uncover new leads for understanding and treating neurodegenerative diseases, along with the brain research behind the collaboration. Greg Brockman amplified the announcement.
Related event: OpenAI Unveils GPT-Rosalind for Neurodegenerative Drug Discovery(2 posts)→
More from Research
- Claude's claimed Riemann proof mocked: 250,000 pages of unreviewed Lean, author calls it 'slop' — GaryMarcus · 2026-11-21
- GGUF 4-bit quantization is just GIF palette compression, 30 years later — carrigmat · 2026-11-21
- Proposed GRH proof by Alessandro Masullo released early; Brian Conrad vetted it for months — zainhas · 2026-11-21
- Human-proposed GRH proof rushed public amid Claude Riemann hype: 'all human, no AI' — zainhas · 2026-11-21
- CT-Bench, a benchmark for LLM agent cooperation via self-negotiated contracts, accepted at COLM 2026 — maxhkw · 2026-11-21
- Frank Nielsen demos geodesic right-angle triangles in dually flat spaces — FrnkNlsn · 2026-11-21